Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilars For US Market May Be Able To Rely On EU-Licensed Reference Products

17 Jul 2018

• By Derrick Gingery

LI-2 Protein_564977620_1200.jpg

Related Content

Biosimilars Need Better Reimbursement, Not 'Kabuki' Coverage, Gottlieb Tells Insurers

08 Mar 2018

US FDA Biosimilar Guidance Update Will Relax Interchangeability Standards

21 Apr 2018

The New 180 Days? Humira Biosimilar Deals Give Amgen 150-Day Jump On Samsung

06 Apr 2018

Generic Company Disclosure Could Be A 'Speedbump' Against Misuse Of US FDA Access Inquiry List

08 Jun 2018

CREATES Act To Face Major Reshaping By Innovator-Friendly Amendments On Senate Floor

14 Jun 2018

Shared REMS: US FDA Wants Brisk Brand-Generic Talks, Might Give Unilateral Waivers

01 Jun 2018

Interchangeable Biosimilars: FDA Clarifies US Reference Not Mandatory For Studies

27 Oct 2017

US FDA Recognizes Eight EU Authorities, Triggers Mutual Recognition Provisions

01 Nov 2017

Biosimilars: Postmarketing Data Alone Not Enough For Interchangeability

18 Jan 2017

US Comparator Requirement For Interchangeable Biosimilars Would Hurt Industry

01 Jun 2017

Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

16 May 2017

FDA's Gottlieb: 'Pricing And Reimbursement Mischief' Holding Back Biosimilar Market

08 Mar 2018

FDA Biosimilar Education Campaign Will Need To Be Targeted

17 Sep 2015

Related Companies

AbbVie Inc.

Viatris Inc.

Samsung Bioepis Co., Ltd.

Amgen, Inc.

Additional Topics

United States Biosimilars Review Pathway Regulation Biologics FDA BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.